Cellectis – gene-editing

Cellectis is a biotech company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART).

Cellectis – gene-editing

Cellectis

Continue reading

TxCell – antigen-specific Type 1 Treg cells

TxCell is a biotech company developing innovative and personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for autoimmune diseases and severe chronic inflammatory diseases.

TxCell – antigen-specific Type 1 Treg cells

txcell Continue reading